tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andy Chen, 1 are a SELL (4.35%), 15 are a BUY (65.22%), 7 are a HOLD (30.43%).
Analyst Andy Chen, currently employed at WOLFE, carries an average stock price target met ratio of 54.17% that have a potential upside of 38.33% achieved within 187 days.
Andy Chen’s has documented 44 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KYMR, Kymera Therapeutics.
Analyst best performing recommendations are on NTLA (INTELLIA THERAPEUTICS).
The best stock recommendation documented was for NTLA (INTELLIA THERAPEUTICS) at 9/24/2025. The price target of $25 was fulfilled within 15 days with a profit of $7.24 (40.77%) receiving and performance score of 27.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Feb-2024
$50
$12.64 (33.83%)
$34
1 months 8 days ago
(04-Aug-2026)
3/6 (50%)
$10.64 (27.03%)
243
Buy Since 11-Aug-2023
$61
$23.64 (63.28%)
$58
2 months 13 days ago
(30-Jun-2026)
1/6 (16.67%)
$22.47 (58.32%)
46
Buy Since 23-May-2023
$62
$23.15 (59.59%)
$44
3 months 17 days ago
(26-May-2026)
3/10 (30%)
$28.17 (83.27%)
119
Hold Since 14-Oct-2025
$30
$-8.85 (-22.78%)
$22
3 months 21 days ago
(22-May-2026)
4/6 (66.67%)
$-4.15 (-12.15%)
431
Buy Since 23-May-2023
$43
$4.15 (10.68%)
$30
3 months 22 days ago
(21-May-2026)
3/4 (75%)
$8.87 (25.99%)
278
Which stock is Andy Chen most bullish on?
Which stock is Andy Chen most reserved on?
What Year was the first public recommendation made by Andy Chen?
